VRTX FY 2017 Earnings — Vertex Pharmaceuticals Incorporated Revenue & Financial Results | Market Cap Arena

VRTXVertex Pharmaceuticals Incorporated

$125B

FY 2017 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$2.5B+46.2% YoY

Gross Profit

$2.2B88.9% margin

Operating Income

$123M5.0% margin

Net Income

$263M10.6% margin

EPS (Diluted)

$1.04

Cash Flow

Operating Cash Flow

$845M

Free Cash Flow

$586M

Stock-Based Comp.

$291M

Balance Sheet

Total Assets

$3.5B

Total Liabilities

$1.5B

Stockholders' Equity

$2.0B

Cash & Equivalents

$1.7B

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$2.5B	$1.7B	+46.2%
Gross Profit	$2.2B	$1.5B	+48.4%
Operating Income	$123M	$10M	+1140.4%
Net Income	$263M	-$112M	+335.1%